Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.

Thyroid : official journal of the American Thyroid Association

Volumn 19, Issue 5, 2009, Pages 495-501

  Nanba, Takashi ^a   Watanabe, Mikio ^a   Inoue, Naoya ^a   Iwatani, Yoshinori ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; AUTOANTIBODY; GAMMA INTERFERON; IL17A PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; INTERLEUKIN 17; INTERLEUKIN 4; THYROTROPIN RECEPTOR; THYROXINE;

ADULT; AGED; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CELL CULTURE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; TH1 CELL; TH2 CELL; TREATMENT OUTCOME;

ADULT; AGED; ANTITHYROID AGENTS; AUTOANTIBODIES; CD4 LYMPHOCYTE COUNT; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH2 CELLS; THYROXINE; TREATMENT OUTCOME;

EID: 67650345273     PISSN: None     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2008.0423     Document Type: Article

References (0)